The PE Ratio as of December 2025 (TTM) for Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) is -15.69

According to Chunghwa Chemical Synthesis & Biotech Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -15.69. This represents a change of -96.64% compared to the average of -466.41 of the last 4 quarters.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) Historical PE Ratio (quarterly & annually)

How has 1762.TW PE Ratio performed in the past?

The mean historical PE Ratio of Chunghwa Chemical Synthesis & Biotech Co., Ltd. over the last ten years is 19.59. The current -15.69 PE Ratio has changed -8109.85% with respect to the historical average. Over the past ten years (40 quarters), 1762.TW's PE Ratio was at its highest in in the June 2016 quarter at 5.18K. The PE Ratio was at its lowest in in the December 2024 quarter at -1820.83.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Chunghwa Chemical Synthesis & Biotech Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) Average PE Ratio

How has 1762.TW PE Ratio performed in the past?

The current PE Ratio of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) PE Ratio vs. Peers

How is 1762.TW’s PE Ratio compared to its peers?

Chunghwa Chemical Synthesis & Biotech Co., Ltd.’s PE Ratio is greater than Advagene Biopharma Co., Ltd. (-24.47), less than Genomics BioSci & Tech. Co.,Ltd. (-10.47), less than Sunny Pharmtech Inc. (-7.79), less than Greenyn Biotechnology Co., Ltd (14.41), greater than Meribank Biotech Co., Ltd (-22.84), less than Hcmed (-12.59), greater than InnoPharmax Inc. (-21.12), greater than Shangya Technology Co., Ltd. (-32.10), less than NaviFUS Corp. (-12.36), less than GlycoNex Incorporation (-11.61),

Build a custom stock screener for Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chunghwa Chemical Synthesis & Biotech Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chunghwa Chemical Synthesis & Biotech Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.